Home Cart Sign in  
Chemical Structure| 1217457-86-7 Chemical Structure| 1217457-86-7

Structure of GGTI298 Trifluoroacetate
CAS No.: 1217457-86-7

Chemical Structure| 1217457-86-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GGTI298 trifluoroacetate is geranylgeranyltransferase I inhibitor. It shows supression of the G1 phase of the cell cycle and induction of apoptosis.

Synonyms: GGTI 298 (trifluoroacetate salt); GGTI 298 TFA salt

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GGTI298 Trifluoroacetate

CAS No. :1217457-86-7
Formula : C29H34F3N3O5S
M.W : 593.66
SMILES Code : CC(C)C[C@H](NC(C1=CC=C(NC[C@@H](N)CS)C=C1C2=C3C=CC=CC3=CC=C2)=O)C(OC)=O.O=C(O)C(F)(F)F
Synonyms :
GGTI 298 (trifluoroacetate salt); GGTI 298 TFA salt
MDL No. :MFCD06409252
InChI Key :WALKWJPZELDSKT-UFABNHQSSA-N
Pubchem ID :16078971

Safety of GGTI298 Trifluoroacetate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GGTI298 Trifluoroacetate

GPCR

Isoform Comparison

Biological Activity

Target
  • Transferase

In Vitro:

Cell Line
Concentration Treated Time Description References
T84WT cells 1 μg/ml 4 h Inhibited FSK-stimulated IK(ap) PMC3711306
RAW264.7 cells 10 μM GGTI298 reversed the inhibition of osteoclast differentiation induced by compression by inhibiting the Rap1a/ERK signaling pathway, thereby accelerating tooth movement. PMC10838930
RAW264.7 cells 2.5 µM 2, 4, and 6 days To evaluate the effect of GGTI298 on autophagic vesicle formation, it was found that GGTI298 significantly reduced the number of autophagic vesicles PMC6844519

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57/BL6 mice Orthodontic tooth movement model Local injection 50 μg/mL Every 2 days for 7 days GGTI298 increased osteoclast activity by inhibiting the Rap1a/ERK signaling pathway, thereby accelerating tooth movement. PMC10838930
Mouse Ileal loop model Ileal loop injection 100 μM Single dose, 6 hours duration Reduced CT-induced fluid accumulation PMC3711306

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.68mL

0.34mL

0.17mL

8.42mL

1.68mL

0.84mL

16.84mL

3.37mL

1.68mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories